Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer

NCT00025532 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Pancreatic Cancer

Interventions

OTHER: iodine I 131 monoclonal antibody CC49-deltaCH2

Sponsor

University of California, San Francisco

Collaborators

[object Object]